Collegium Pharmaceutical Inc
NASDAQ:COLL
Collegium Pharmaceutical Inc
Cash from Investing Activities
Collegium Pharmaceutical Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Collegium Pharmaceutical Inc
NASDAQ:COLL
|
Cash from Investing Activities
-$70.8m
|
CAGR 3-Years
43%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash from Investing Activities
-$2.9B
|
CAGR 3-Years
48%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash from Investing Activities
-$21.7B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pfizer Inc
NYSE:PFE
|
Cash from Investing Activities
-$32.3B
|
CAGR 3-Years
-76%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
Cash from Investing Activities
-$14.1B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-9%
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash from Investing Activities
-$7.6B
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-10%
|
See Also
What is Collegium Pharmaceutical Inc's Cash from Investing Activities?
Cash from Investing Activities
-70.8m
USD
Based on the financial report for Dec 31, 2023, Collegium Pharmaceutical Inc's Cash from Investing Activities amounts to -70.8m USD.
What is Collegium Pharmaceutical Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-24%
Over the last year, the Cash from Investing Activities growth was 88%. The average annual Cash from Investing Activities growth rates for Collegium Pharmaceutical Inc have been 43% over the past three years , -24% over the past five years .